FI68819C - Foerfarande foer framstaellning av tiazolidin-2,4-dioner vilkaaer anvaendbara saosom antikonvulsiva och antidepressiva maeen - Google Patents

Foerfarande foer framstaellning av tiazolidin-2,4-dioner vilkaaer anvaendbara saosom antikonvulsiva och antidepressiva maeen Download PDF

Info

Publication number
FI68819C
FI68819C FI783995A FI783995A FI68819C FI 68819 C FI68819 C FI 68819C FI 783995 A FI783995 A FI 783995A FI 783995 A FI783995 A FI 783995A FI 68819 C FI68819 C FI 68819C
Authority
FI
Finland
Prior art keywords
group
formula
thiazolidine
compound
phenyl
Prior art date
Application number
FI783995A
Other languages
English (en)
Finnish (fi)
Other versions
FI783995A (fi
FI68819B (fi
Inventor
Dennis Claude Bigg
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7739559A external-priority patent/FR2413381A1/fr
Priority claimed from FR7833244A external-priority patent/FR2442232A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI783995A publication Critical patent/FI783995A/fi
Publication of FI68819B publication Critical patent/FI68819B/fi
Application granted granted Critical
Publication of FI68819C publication Critical patent/FI68819C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI783995A 1977-12-29 1978-12-27 Foerfarande foer framstaellning av tiazolidin-2,4-dioner vilkaaer anvaendbara saosom antikonvulsiva och antidepressiva maeen FI68819C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7739559A FR2413381A1 (fr) 1977-12-29 1977-12-29 Derives de thiazolidinedione et leur application en therapeutique
FR7739559 1977-12-29
FR7833244A FR2442232A2 (fr) 1978-11-24 1978-11-24 Derives de thiazolidinedione-2,4 et leur application en therapeutique
FR7833244 1978-11-24

Publications (3)

Publication Number Publication Date
FI783995A FI783995A (fi) 1979-06-30
FI68819B FI68819B (fi) 1985-07-31
FI68819C true FI68819C (fi) 1985-11-11

Family

ID=26220372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783995A FI68819C (fi) 1977-12-29 1978-12-27 Foerfarande foer framstaellning av tiazolidin-2,4-dioner vilkaaer anvaendbara saosom antikonvulsiva och antidepressiva maeen

Country Status (17)

Country Link
US (1) US4349683A (de)
EP (1) EP0002978B1 (de)
JP (1) JPS6011908B2 (de)
AR (1) AR223160A1 (de)
AT (1) AT370098B (de)
AU (1) AU517221B2 (de)
CA (1) CA1107740A (de)
DE (1) DE2862059D1 (de)
DK (1) DK149429C (de)
ES (1) ES476408A1 (de)
FI (1) FI68819C (de)
GR (1) GR65312B (de)
IE (1) IE47902B1 (de)
IL (1) IL56304A (de)
NO (1) NO148454C (de)
NZ (1) NZ189300A (de)
PT (1) PT68991A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPH0750560B2 (ja) * 1981-05-09 1995-05-31 ヤマハ株式会社 ディジタル集積回路装置
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20150068829A (ko) * 2013-12-12 2015-06-22 삼성전자주식회사 알킬 암모늄염 화합물을 포함하는 유도 용질

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation

Also Published As

Publication number Publication date
JPS6011908B2 (ja) 1985-03-28
EP0002978A3 (en) 1979-07-25
CA1107740A (en) 1981-08-25
ES476408A1 (es) 1979-04-01
DK149429C (da) 1987-03-09
IL56304A0 (en) 1979-03-12
IE47902B1 (en) 1984-07-25
EP0002978B1 (de) 1982-10-06
NO784382L (no) 1979-07-02
AU4296178A (en) 1979-07-05
IE782561L (en) 1979-06-29
AT370098B (de) 1983-02-25
DK582578A (da) 1979-06-30
FI783995A (fi) 1979-06-30
NZ189300A (en) 1980-05-27
ATA936678A (de) 1982-07-15
AU517221B2 (en) 1981-07-16
NO148454B (no) 1983-07-04
GR65312B (en) 1980-08-02
DE2862059D1 (en) 1982-11-11
NO148454C (no) 1983-10-12
AR223160A1 (es) 1981-07-31
FI68819B (fi) 1985-07-31
JPS5498758A (en) 1979-08-03
DK149429B (da) 1986-06-09
EP0002978A2 (de) 1979-07-11
US4349683A (en) 1982-09-14
PT68991A (fr) 1979-01-01
IL56304A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
SU1544186A3 (ru) Способ получени амидов
US3299067A (en) 2-[1'-(benzyl and phenyl)-4'-piperazinyl]-pyrimidine derivatives
KR920000761B1 (ko) 치환된 2-피리미디닐-1-피페라진 유도체의 제조방법
Dogruer et al. Anti-nociceptive and anti-inflammatory activity of some (2-benzoxazolone-3-yl and 2-benzothiazolone-3-yl) acetic acid derivatives
FI68819C (fi) Foerfarande foer framstaellning av tiazolidin-2,4-dioner vilkaaer anvaendbara saosom antikonvulsiva och antidepressiva maeen
NO162977B (no) Filt for fremstilling av en vaatpressefilt for en papirmaskin, samt fremgangsmaate ved fremstilling derav.
SK10802002A3 (sk) 1,3-Disubstituované pyrolidíny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok, ktorý ich obsahuje
FI60010C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(2-imidazolin-2-ylamino)-2,1,3-bensotiadiazoler
EA005128B1 (ru) Новые производные дифенилмочевины, способ их получения и содержащие их фармацевтические композиции
Jiang et al. Synthesis of novel 7-substituted-5-phenyl-[1, 2, 4] triazolo [1, 5-a] pyrimidines with anticonvulsant activity
US3428646A (en) 4-imidazolidones and processes for preparing same
SK130694A3 (en) 1-£2h-1-benzopyran-2-on-8-yl| pyperazine derivatives, method of their production, pharmaceutical agents containing these compounds as effective matters and their using
CA1247101A (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds, intermediates and methods for their preparation, and pharmaceutical compositions containing them
US4086353A (en) Certain azolinylamino (azolidinylimino) indazoles
US3517007A (en) 5 - acetamido - 4 - pyrimidinecarboxamides,5 - acetamido - 4 - pyrimidinecarboxylic acid hydrazides and related compounds
JPS63310872A (ja) ドーパミン−β−ヒドロキシラーゼ抑制剤
EP4061352A1 (de) Verbindungen und verfahren zur herstellung von s1p1-modulierenden verbindungen
US4318915A (en) Substituted guandines and methods of preparation thereof
US3953467A (en) Pyrazole derivatives and process for preparing the same
US4665083A (en) Iminothiazolidine derivatives
US4208420A (en) New benzo [d] thiazole derivatives, process for their preparation and their therapeutic applications
NO180585B (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive benzoksazinon- og benzotiazinonderivater og mellomprodukter
KR940021532A (ko) 헤테로시클릭 치환된 페닐아세트산 유도체의 페닐글리산아미드
US4115407A (en) N-Benzyl-4-chromanamines
Glushkov et al. Synthesis and antiinflammatory and analgesic activity of amidines of 3, 4-dihydroisoquinoline series

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SYNTHELABO